Ignite Creation Date:
2024-05-06 @ 9:58 AM
Last Modification Date:
2024-10-26 @ 12:22 PM
Study NCT ID:
NCT03123783
Status:
COMPLETED
Last Update Posted:
2023-12-26
First Post:
2017-04-17
Brief Title:
CD40 Agonistic Antibody APX005M Sotigalimab in Combination With Nivolumab
Sponsor:
Apexigen America Inc
Organization:
Apexigen America Inc